Valuation : Oxford BioDynamics Plc

Market Cap 6.01M 6.97M 5.65M 5.15M 9.68M 661M 9.75M 66.95M 26.02M 337M 26.15M 25.58M 1.12B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10.91M 12.65M 10.27M 9.36M 17.58M 1.2B 17.7M 122M 47.25M 611M 47.48M 46.45M 2.03B EV / Sales 2026 *
5.83x
EV / Sales 2027 * -
Free-Float
94.62%
Yield 2026 *
-
Yield 2027 * -
1 week-7.69%
1 month+9.09%
3 months-35.14%
6 months-53.85%
Current year-44.19%
1 week 0.11
Extreme 0.11
0.13
1 month 0.1
Extreme 0.1
0.15
Current year 0.08
Extreme 0.08
0.34
1 year 0.08
Extreme 0.08
0.75
3 years 0.08
Extreme 0.08
52
5 years 0.08
Extreme 0.08
53.6
10 years 0.08
Extreme 0.08
278.82
Manager TitleAgeSince
Chief Executive Officer - 29/06/2026
Chief Tech/Sci/R&D Officer 64 07/06/2007
Director of Finance/CFO - 14/09/2017
Director TitleAgeSince
Director/Board Member 64 07/06/2007
Director/Board Member - 14/09/2017
Director/Board Member 65 04/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
10/11/25 Free

Founder

15,000,000 0.7663%
10/11/25 Free

Executive/Senior Manager

15,000,000 0.7663%
10/11/25 Free

Chief Operating Officer

15,000,000 0.7663%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.69%-74.74%-98.92% 6.98M
+2.38%+0.35%-13.85%-29.85% 2.48B
+1.43%+17.65%+17.20%-82.37% 2.22B
+0.63%-3.13%-15.64%-8.05% 353M
-0.22%+2.23%-44.55% - 53.61M
Average +0.84%+1.79%-26.32%-54.80% 1.02B
Weighted average by Cap. +1.82%+5.93%-0.89%-51.49%

Financials

2026 *2027 *
Net sales 1.87M 2.17M 1.76M 1.61M 3.02M 206M 3.04M 20.86M 8.11M 105M 8.15M 7.97M 348M -
Net income - -
Net Debt 4.9M 5.68M 4.61M 4.21M 7.9M 540M 7.95M 54.63M 21.23M 275M 21.34M 20.87M 911M -
Logo Oxford BioDynamics Plc
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
Employees
-
Date Price Change Volume
01/09/26 GBX 0.1200 0.00% 2,665,486
28/08/26 GBX 0.1200 +2.56% 21,540,567
27/08/26 GBX 0.1170 0.00% 11,495,458
26/08/26 GBX 0.1170 -4.10% 159,729,348
25/08/26 GBX 0.1220 -6.15% 938,302
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001200GBP
Average target price
0.0100GBP
Spread / Average Target
+733.33%

Annual profits - Rate of surprise